Objectives: To evaluate the volumetric changes and peri-implant health at implant sites with and without previous soft tissue grafting over a 5-year observation period.
Following tooth extraction, remodeling processes are initiated, leading to morphological changes of the surrounding soft and hard tissues (Araujo & Lindhe 2005) . A regeneration of the missing volume is inevitable for implant treatment in the esthetic zone. In order to achieve an optimal tissue volume, an augmentation of the hard as well as of the soft tissues appears to be a prerequisite (Schneider et al. 2011) .
Guided bone regeneration (GBR) is a predictable treatment modality to regenerate bone (Buser et al. 1990 ). Moreover, implant survival rates are reported to be high irrespective of whether implants were placed in native or in augmented bone (Hammerle et al. 2002) . GBR has further shown to be effective to regenerate volume along the mucosal margin in terms of tissue height and thickness (Benic et al. 2017) .
Apart from hard tissue augmentation, soft tissue volume augmentation is considered a frequently used step during implant therapy in the esthetic zone. Soft tissue volume augmentation is usually carried out by the use of a subepithelial connective tissue graft (SCTG), a technique described in the 1980s (Langer & Calagna 1982) . Many studies using SCTGs were performed for root coverage procedures (Cairo et al. 2008; Cheng et al. 2015) , for gain of keratinized tissue or for pontic sites (Gonzalez-Martin et al. 2014; Sanz-Martin et al. 2016) . SCTG were also used in conjunction with dental implant placement, either simultaneously or during the healing phase of the implant. Beneficial outcomes in terms of the soft tissue contour, esthetics and the facial mucosal level were reported at implant sites (Yoshino et al. 2014; Migliorati et al. 2015; Boardman et al. 2016) .
Various methods have been described in the literature to assess esthetic outcomes of implants, peri-implant tissues and implantsupported reconstructions. This included analyses of the clinical crown height, the extent of recession (Chambrone et al. 2008) , the white esthetic score (Belser et al. 2009 ), the pink esthetic score (Furhauser et al. 2005) and the papilla fill (Jemt 1997) . From a clinical point of view, a three-dimensional analysis monitoring the changes of the periimplant tissues over time is desired. Data on volumetric changes of the peri-implant tissues, however, are still limited to 1-year reports (Schneider et al. 2011; De Bruyckere et al. 2015) . Moreover, no information is available in the literature assessing the effect of soft tissue augmentation procedures at implant sites with a longer follow-up.
Apart from volumetric and linear changes that predominantly assess the peri-implant tissues from an esthetic point of view and do not reflect the health status, the long-term periodontal status of implant sites is of scientific interest. From a biologic point of view, it is unknown whether or not soft tissue volume grafting at implant sites results in a more favorable biologic response than untreated controls.
The aim of the present study was, therefore, to evaluate three-and two-dimensional changes and the peri-implant health at implant sites with or without soft tissue grafting over a 5-year observation period.
Material and methods

Study design
This study was designed as a retrospective case-control study. Partially edentulous patients with dental implants placed in the esthetic area of the maxilla were selected from a patient pool reported in an earlier randomized controlled clinical trial (Thoma et al. 2014b) (Thoma et al. 2014b) . For the present study, only patients with a fixed reconstruction and at least one implant in the esthetic region 15-25 were included. In case patients had received more than one implant eligible for the study, one site was randomly selected. Out of this patient pool, 18 patients could finally be included. Eight patients had received a SCTG 4-6 weeks prior to abutment connection (test), whereas 10 patients did not receive any soft tissue volume augmentation during implant therapy (control).
Surgical procedures
In all 18 patients, dental implant placement was performed according to the standard of care at the Clinic of Fixed and Removable Prosthodontics and Dental Material Science. GBR procedures were performed at all 18 implant sites simultaneously with dental implant placement. Deproteinized bovine bone mineral (DBBM) (Bio-Oss â Granules or Bio-Oss Collagen â ; Geistlich Pharma AG, Wolhusen, Switzerland) and a collagen membrane (Bio-Gide â ; Geistlich Pharma AG) were used in all cases for GBR. Three to four months after implant placement, patients of the test group received a SCTG ( Fig. 1a-f ), and abutment connection was performed 4-6 weeks later. In the control group, abutment connection was performed 3-4 months after implant placement. The decision to perform an additional soft tissue volume augmentation was based on esthetic reasons, mainly including a volume deficit on the buccal side of the implants and depending on whether or not the patients agreed on the additional procedure. The decision was not based on a biological reason, and implant surfaces were supposed to be surrounded by bony structures after the GBR procedure. Soft tissue volume augmentation was performed using a full-flap crestal approach on top of the implant including an elevation of the papillae, merging into a split thickness flap at the buccal aspect or a minimally invasive approach without elevating the papillae. In brief, a pouch was prepared according to the expected size of the transplant using either sulcular incisions and a crestal incision connecting the palatal line angles of the adjacent teeth or a minimally invasive approach without elevation of the papillae (Fig. 1e,f) . A split thickness flap was then prepared, leaving the periosteum attached to the bone. Subsequently, a SCTG (Fig. 1c) , harvested from the palate by means of a single-incision technique (Fig. 1d) , was placed into the vestibular pocket (Fig. 1e,f) . The donor site was closed by a cross-sectional suture (Gore-tex â 5-0 sutures, W.L.
Gore & Associates, Flagstaff, AZ, USA). Abutment connection was performed 3-4 months after implant placement (control) or 4-6 weeks after soft tissue augmentation (test) following the same protocol for all patients. Subsequently, for all implants screw-retained fixed single crowns or fixed dental prostheses were fabricated and inserted.
Clinical examinations
All patients were included in a regular maintenance interval at the Clinic of Fixed and Removable Prosthodontics and Dental Material Science. Follow-up examinations were scheduled 1 week after the insertion of the final reconstruction (baseline) and then yearly up to 5 years (5Y). At baseline and at 5 years ( Fig. 1g,h ), a thorough clinical examination was performed (Thoma et al. 2014b) . Moreover, alginate impressions of the implant sites were taken.
Processing of casts, image acquisition and matching of stereolithographic models
The casts (baseline, 5Y) made of dental stone were examined meticulously for irregularities at the implant site, along the buccal mucosal margin and the apical region, as well as in the papilla regions. All casts were then scanned with a desktop 3D scanner (Imetric 3D, Courgenay, Switzerland). The obtained stereolithographic files (standard tessellation language, STL) were imported into an image analysis software (Swissmeda Software, Swissmeda AG, Zurich, Switzerland). The baseline and 5Y STL files were automatically superimposed by the software program and thereafter manually adjusted for optimal superimposition of the implant site (Fig. 2) .
Data evaluation
Two calibrated examiners independently performed all measurements on the superimposed STL files. Both researchers were experienced in performing this type of analysis. Variables in terms of peri-implant health were recorded at the clinical examinations according to a previously described protocol (Thoma et al. 2014b ).
Volumetric measurements
At the buccal aspect of the implant site, a region of interest (ROI) was selected according to a protocol described previously (Schneider et al. 2011; ).
The ROI represented the esthetically critical area at implant sites as well as the area where the SCTG was placed (in case soft tissue augmentation was performed). The coronal border of the ROI was selected 1mm below the mucosal margin of the baseline scan, the apical border at 5 mm below the mucosal margin. The locations of the mesial and distal borders varied between the sites, but were standardized to 1 mm apart from the contact point of the adjacent teeth (Fig. 3) . The software calculated the area of the selected ROI, the volume between the two surfaces and the mean distance between the surfaces (baseline and 5Y). As the volume is highly dependent on the size of the selected area, the data are expressed as mean distance (mm; MD).
Linear measurements
A cross section, representing the central implant axis, was selected to measure the crown height, representing the distance between the incisal edge of the baseline STL file to the buccal mucosal margin at baseline and at 5Y. One measurement point was placed at the incisal edge of the baseline model. From this point, the first measurement was taken to the mucosal margin at baseline and the second to the margin at 5 years. The differences between the two measurements/time points represent the change of the buccal marginal mucosal level (mm; bMML change ) (Fig. 4a) . The ridge width at the buccal aspect of the implant was measured using the same cross section at baseline and at 5Y. Measurements were taken horizontally at three levels below the mucosal margin: 1 mm (mm; RW1 change ), 3 mm (mm; RW3 change ) and 5 mm (mm; RW5 change ) (Fig. 4b) . These measurements represented changes in peri-implant tissue thickness.
Papilla index
The papilla index (Jemt 1997 ) was evaluated on both (baseline, 5Y) STL files separately for the mesial (PI mesial ) and distal papilla (PI distal ). This index includes the following scoring system: 0 = no papilla present, 1 = less than half of the height of the papilla present, 2 = half or more of the papilla present, 3 = papilla fills up the entire proximal space, 4 = hyperplastic papilla.
Peri-implant health
The health of the peri-implant tissues was assessed by recordings of probing pocket depth values (PPD, mm), bleeding on probing (BOP, positive or negative, %) and plaque index (PlI, positive or negative, %) at six sites per implant at baseline and at the 5-year follow-up. Healthy tissues are defined by the absence of BOP and PPD <6 mm.
Statistical analysis
Data were recorded in Excel (Microsoft Corporation, Redmond, Washington, USA), and statistical analysis was performed with SAS 9.4 (SAS Corp., Cary NC. USA). The differences between the two examiners (VS and SB) were analyzed by Wilcoxon signed-rank test. An intergroup comparison between the medians of the test and control group was performed by Wilcoxon-Mann-Whitney test. The influence of the site was tested for side as well as anterior-posterior. Hodges-Lehmann estimation (HLest) and Spearman's rank correlation were performed. The Hodges-Lehmann estimation of the differences between the groups and corresponding nonparametric confidence intervals are presented in Table A1 in Appendix. The level of significance was set at 5%.
Results
Seven male and 11 female patients with a median age of 59.4 years (Min: 27; Max: 76.6) at the 5-year follow-up completed the investigation with a median follow-up time of 60.5 months (Min: 53; Max: 152). There were two smokers in the study population, both belonging to the control group. No complications occurred in all included patients and implant sites during the follow-up period. No statistically significant effect of the site was found (P > 0.114). The differences between the two examiners (VS and SB) were determined by Wilcoxon signed-rank test and were not statistically significantly different with P-values higher than 0.1231 (Table 1) . The averaged data measured by the two examiners in terms of MD, bMML change and RW change are enlisted in Table 2 , and descriptive results of all assessed variables are shown in The papilla index revealed a slight reduction over time at the mesial and distal papilla in both groups. All results demonstrated no statistically significant differences between the groups (P > 0.35). The measurements of MD, CH change and RW change correlated since all correlations were between 0.684 and 0.88.
Median PPD was 3.20 mm (Min: 2.80; Max: 4.80) (test) and 2.75 mm (Min: 1.50; Max: 5.00) (control) at baseline and increased slightly to 3.67 mm (Min: 2.67; Max: 5.00) (test) and 3.33 mm (Min: 2.00; Max: 6.67) (control) at 5 years. The median values for BOP amounted 25% (Min: 0%; Max: 75%) (test) and 38% (Min: 0%; Max: 88%) (control) at baseline and measured 31% (Min: 13%; Max: 75%) (test) and 31% (Min: 0%; Max: 75%) (control) at 5 years. The respective median values for PlI were 0% (Min: 0%; Max: 50%) (test) and 0% (Min: 0%; Max: 75%) (control) at baseline and 0% (Min: 0%; Max: 33%) (test) and 13% (Min: 0%; Max: 50%) (control) at 5 years. None of these differences between the groups were statistically significantly different between the groups at any time-point (P > 0.05). There were some missing data in terms of RW5 change due to the fact that the variable could only be assessed if the level of measurement was within the keratinized tissue (coronal to the mucogingival junction). In one patient, PI distal was not assessed because the test site 15 was the last tooth in a shortened dental arch. Smoking was only reported at baseline, and clinical parameters were missing for one patient belonging to the test group (respectively, 2 patients for PlI).
Discussion
This retrospective controlled study evaluated the peri-implant tissue stability in patients treated with or without SCTG over an observation period of 5 years. The study demonstrated minimal changes in terms of (i) mean distance in the selected buccal ROI and (ii) vertical and horizontal tissue reduction without statistically significant differences between the groups. These findings were supported by correlations found between volumetric and linear measurements. In addition, soft tissue volume augmentation at implant sites demonstrated neither a benefit nor a disadvantage in terms of the long-term biologic response.
The obtained data revealed a high consistency. The mean distance within the region of interest showed minimum and maximum values within 1 mm, the change of the buccal marginal mucosal level within 1.1 mm and the change of the ridge width within 1.7 mm. There was no trend for a higher variance in one of the groups with respect to all obtained variables. In general, a tissue loss of 0.5 mm of the buccal peri-implant tissues within 5 years was detected in both groups. This finding is in line with the results of other studies after a 1-year follow-up (Schneider et al. 2011; De Bruyckere et al. 2015) . Translating this into a clinical Lowest P-value was P = 0.1231. N = number, SD = standard deviation, Min = minimum, Q1 = 25% quartile, Q3 = 75% quartile, Max = maximum, PROB = probability (P-value), bMML = buccal marginal mucosal level, RW = ridge width, PI = papilla index.
environment, 0.5 mm of loss might be considered as clinically acceptable in the esthetic region, keeping in mind that such minimal changes might not be perceived by the naked eye. One has to bear in mind that healthy tissues around natural teeth present changes over longer observation periods as well, but studies with comparable measurement techniques are not available. Measurement of an untreated site to obtain a positive control was rejected for two reasons: (i) Contralateral teeth in the esthetic region were often affected by the treatment and therefore could not serve as an accurate control; (ii) a comparison with posterior teeth would be affected by many additional factors. The performed measurements, linear and volumetric, analyze the overall change of the peri-implant tissues. Thus, the combined effect of the soft and hard tissue changes was measured. As the study is focusing on the As Table 1 did not reveal statistically significant differences between the two examiners, the means of both measurements are shown. CM, collagen membrane; DBBM, deproteinized bovine bone mineral; IP, implant placement; AB, autologous bone block. The mean of both examiners is shown. N = number, SD = standard deviation, Min = minimum, Q1 = 25% quartile, Q3 = 75% quartile, Max = maximum, bMML = buccal marginal mucosal level, RW = ridge width, PI = papilla index, PPD = probing pocket depth, BOP = bleeding on probing, PlI = plaque index.
soft tissue, the hard tissue component had to be highly standardized. Only patients with GBR by means of a CM and DBBM at the time of implant placement were included in this study. At the time-point of baseline impression taking, the GBR procedure was at least 4 months ago and can be considered to be stable, as DBBM is documented to have a very low resorption rate (Araujo et al. 2002) . The materials used for GBR are reported to obtain high volume stability clinically (Buser et al. 2013; Jensen et al. 2014) . Two patients were additionally in need of a prior bone augmentation by means of an autologous bone block. The results in terms of volume stability in these two cases were averaged and in line with the findings in other patients. The soft tissues underlie changes as well, first due to the integration process at the recipient site, which is documented to occur during the first 4-6 weeks (Allen et al. 1985; Studer et al. 2000; Rotenberg & Tatakis 2014) . Furthermore, major changes occur due to the treatment in terms of abutment connection and soft tissue conditioning by means of provisional crowns. At the time of the baseline impression, soft tissue grafting was at least 3 months ago. As the aim of this study was to assess longterm stability, not early changes, the timepoint of impression taking can be considered to be ideal and cannot be chosen earlier due to changes caused by the prosthetic treatment.
Because the potential of SCTG is very high to replace missing tissue volume to a considerable extent (Thoma et al. 2014a; Bassetti et al. 2016) , this technique remains the gold standard for soft tissue augmentation in dentistry. Very different prerequisites for the soft tissue are present around dental implants compared to teeth, in terms of attachment to the surface, but also nutrition due to the missing periodontal ligament. The connective tissue gathered from the palate has proven a good integration at these sites regardless of these circumstances. Furthermore, this study provides further evidence that the soft tissues remain as stable as nongrafted sites on the long term, which justifies this treatment accompanied with a certain morbidity. From a patient's perspective, the treatment with a SCTG is an intervention associated with a relatively high morbidity (Sanz et al. 2009; Lorenzo et al. 2012 ) and a solid volume gain and continuing stability are therefore of paramount importance.
The PI decreased minimally over time for the mesial and distal values in both groups. This finding is in contradiction with studies reporting of an early recovery of the papilla within the first years (Jemt 1997; Grunder 2000; Raes et al. 2015) . Eventually, this might be due to the longer observation period in the present study. One might speculate that following an increase in the first year, changes in papilla height occurred between year 1 and year 5. Moreover, PI values were in general low in patients with adjacent implants (three test and one control). This finding is reasonable as it is well documented that the creation of a papilla between implants is more difficult to achieve compared to sites with at least one neighboring tooth (Tarnow et al. 2003) . No correlations were found between peri-implant tissue changes on the buccal side and changes of the papilla height.
The assessment of peri-implant health revealed, in general, healthy tissues with only two PPD values exceeding 5 mm. The obtained results are in line with findings in other studies, except for BOP, which, in both groups, appeared to have relatively high values. However, other studies found BOP values that were even higher at a 5-year follow-up (van Velzen et al. 2015; Becker et al. 2016; Brandenberg et al. 2016 ).
The present results are limited by the following facts: (i) retrospective study design, (ii) small sample size, (iii) data were extracted from a RCT comparing two implant systems, without focusing on soft and hard tissue augmentations at that time, even if the site seemed not to have an impact on the outcome variables according to the statistical test.
Conclusion
Implant sites with and without soft tissue grafting on the buccal side revealed only minimal changes over 5 years based on volumetric and linear outcome measures without significant differences between the two groups. Periodontal parameters remained stable over time. The use of a SCTG based on an esthetic indication resulted in similar biological outcomes compared to non-grafted implant sites. The small sample size and retrospective study design must be taken into account when drawing conclusions and recommendations for clinicians.
